Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000904454-10-000117
Filing Date
2010-04-09
Accepted
2010-04-09 16:38:15
Documents
1
Period of Report
2010-04-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 7742
  Complete submission text file 0000904454-10-000117.txt   9989
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Reporting) CIK: 0000200406 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 0209
Type: 3 | Act: 34 | File No.: 001-34688 | Film No.: 10742989
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
JOHNSON & JOHNSON DEVELOPMENT CORP ET AL (Reporting) CIK: 0000924020 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34688 | Film No.: 10742988

Mailing Address 2900 POTSHOP LANE SUITE 100 EAST NORRITON PA 19403
Business Address 2900 POTSHOP LANE SUITE 100 EAST NORRITON PA 19403 267-960-4800
TENGION INC (Issuer) CIK: 0001296391 (see all company filings)

EIN.: 200214813
SIC: 2836 Biological Products, (No Diagnostic Substances)